Daily Aspirin in Eligible People 3 Times Higher in Wealthy Countries In the United States, a monthly supply of baby aspirin (81 milligrams per dose) can cost as little as 5 cents a day, according to GoodRx. Low-dose daily aspirin helps prevent blood clots from forming, including ones that could cut off blood flow to an area of the heart or brain, causing a heart attack or stroke.Ĭost is another reason that daily aspirin therapy is seen as a potential way to move the needle - aspirin is also generally affordable, according to the authors. To help achieve that goal, the WHO aims to have 50 percent of eligible people taking a daily low-dose aspirin by 2025.Īspirin is recommended for secondary prevention of heart attack because of decades of evidence, with large prevention trials published by the Centers for Disease Control and Prevention (CDC) that date back to the late 1980s, showing that it can reduce the risk of a second cardiovascular event, such as a second heart attack or stroke, by about one-quarter. The United Nations Sustainable Development Goal (STG) has a target of reducing one-third of premature deaths from noncommunicable diseases (such as heart events) by 2030 through prevention and treatment. Daily Aspirin Use Part of Worldwide Strategy to Reduce Premature Deaths Shapiro, who was not involved in the study. “The large sample size across diverse countries makes this a robust estimate of the gap between recommendations and actual aspirin use, evidence that can be used to inform efforts to improve adherence and prevent recurrent cardiovascular events,” says Dr. “These findings are important because they provide a comprehensive picture of the underutilization of aspirin for secondary prevention of cardiovascular disease globally, particularly in low- and middle-income countries,” says Michael Shapiro, DO, a professor of cardiology at Wake Forest University School of Medicine and cardiologist at Atrium Health Wake Forest Baptist in Winston Salem, North Carolina. Investigators found that in lower income countries, such as Ethiopia and Afghanistan, only 1 in 6 people (16.6 percent) took daily aspirin for secondary prevention compared with nearly 2 in 3 (65 percent) in higher income countries like the United States and the United Kingdom. “We know from existing data that there are benefits of aspirin for secondary prevention of cardiovascular disease, but our findings suggest that aspirin use is suboptimal across the world, and particularly lower showing some disparities in aspirin use among different strata of incomes,” says Dr. Survivors of heart attacks and stroke often have a high risk of having future cardiovascular events, which can be fatal, says first author Sang Gune Yoo, MD, a cardiovascular disease fellow at Washington University School of Medicine in St. But a new study suggests that thousands of those early deaths are preventable, given that only 40 percent of eligible patients are taking daily aspirin to prevent a second heart attack or stroke (called secondary prevention), according to a new study published on August 22 in JAMA. Coronary heart disease, stroke, and chronic obstructive pulmonary disease are the top three causes of death worldwide, accounting for an estimated 1 and 3 deaths, per the World Health Organization (WHO).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |